Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_assertion type Assertion NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_head.
- NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_assertion description "[To better understand factors regulating TPO levels, we measured blood levels of TPO in patients with impaired platelet production due to aplastic anemia (AA) and with platelet destructive disorders, including idiopathic thrombocytopenic purpura (ITP), posttransfusion purpura (PTP), drug purpura (DP), and X-linked thrombocytopenia (XLTP).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_provenance.
- NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_assertion evidence source_evidence_literature NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_provenance.
- NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_assertion SIO_000772 8639762 NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_provenance.
- NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_assertion wasDerivedFrom befree-20140225 NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_provenance.
- NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_assertion wasGeneratedBy ECO_0000203 NP227945.RAO2rnRM9J2TpO0l241jPhglKYF4J3d7v8FP4MiweehLY130_provenance.